HRV Chart for Females: Normal Ranges, Menstrual Cycle & Age Factors

Women typically have HRV (RMSSD) values 5-15% lower than men of the same age, and their HRV fluctuates cyclically with the menstrual cycle, dropping during the luteal phase and rising during the follicular phase. These sex-specific patterns mean that women interpreting their HRV data against population-average charts may be comparing themselves to an inappropriate reference. In this article, we provide female-specific normative HRV data by age, explain the hormonal mechanisms that drive HRV variation in women, and offer practical guidance for female athletes and health-conscious women using wearable HRV tracking.

For general HRV normative data across both sexes, see our comprehensive HRV chart by age. This article focuses specifically on the factors that make female HRV interpretation unique.

Female-Specific HRV Normative Data by Age

The following values represent estimated female averages for RMSSD measured at rest or during sleep. These are derived from studies including Koenig and Thayer (2016), Nunan et al. (2010), and additional large-cohort data that stratified by sex. Note that individual variation remains substantial within every age group.

Key observations from the data:

• The sex difference in HRV is present across all adult age groups but is most pronounced during the reproductive years (approximately ages 25-50).
• After menopause (typically ages 48-55), the gap between male and female HRV narrows, supporting the role of reproductive hormones in driving the difference.
• The absolute decline in HRV from the twenties to the sixties is proportionally similar in both sexes (approximately 55-60% reduction).
• Individual variation within each age group spans a 3-4x range, meaning that fitness, lifestyle, genetics, and measurement conditions often matter more than sex alone.

Why Women Have Lower HRV Than Men

Several interconnected mechanisms contribute to the consistent sex difference in HRV:

• Higher resting heart rate. Women have resting heart rates that are, on average, 3-5 BPM higher than men, related to smaller cardiac chamber size and lower stroke volume. Since heart rate and HRV are inversely related, this partially explains the gap.
• Hormonal influences. Estrogen is associated with enhanced parasympathetic tone (higher HRV during the follicular phase), while progesterone shifts autonomic balance toward sympathetic dominance (lower HRV during the luteal phase). This interplay creates cyclical HRV patterns unique to women of reproductive age.
• Cardiac anatomy. Women have, on average, smaller hearts, thinner ventricular walls, and shorter QT intervals. These structural differences affect the electrophysiological substrate for heart rate variability.
• Autonomic differences. Research suggests women may have relatively greater sympathetic and lower parasympathetic cardiac modulation compared to men at the same age, though findings vary across studies.

The Menstrual Cycle and HRV

The menstrual cycle creates predictable, recurring fluctuations in HRV that are important to understand for accurate interpretation of wearable data.

Follicular Phase (Days 1-14)

The follicular phase begins on the first day of menstruation and ends at ovulation. During this phase:

• Estrogen levels gradually rise, peaking just before ovulation
• Progesterone levels remain low
• HRV tends to be at its highest during this phase, particularly in the late follicular phase approaching ovulation
• Parasympathetic tone is relatively enhanced
• This is often when female athletes feel their best and when training capacity may be highest

Luteal Phase (Days 15-28)

The luteal phase follows ovulation and ends when menstruation begins. Progesterone rises sharply, core body temperature increases by approximately 0.2-0.5 degrees Celsius, and HRV decreases by approximately 5-15% compared to the follicular phase (Schmalenberger et al., 2019). Resting heart rate may increase by 2-5 BPM, and many women report reduced exercise tolerance and increased fatigue.

Research shows the average RMSSD difference between follicular and luteal phases is 3-8ms (10-20% relative change). The magnitude varies by individual, but the pattern is consistent within individuals from cycle to cycle.

This cyclical variation has important implications: a woman might see a "low" HRV reading during the luteal phase and mistakenly attribute it to poor recovery or overtraining when it actually reflects normal hormonal physiology. Understanding your cycle phase is essential for contextualizing daily readings.

How Oura and WHOOP Use Cycle-Aware HRV Tracking

Modern wearables are beginning to account for menstrual cycle effects on HRV and other biometrics:

Oura Ring

Oura Ring tracks skin temperature continuously. Because core temperature rises during the luteal phase, Oura can detect cycle phase transitions through temperature data combined with HRV patterns. The Oura app includes:

• Cycle prediction based on temperature shift detection
• Period prediction that helps contextualize readiness and recovery scores
• Natural cycle tracking that does not require manual logging (though manual input improves accuracy)

The Oura Ring's finger-based PPG sensor provides particularly clean HRV data for cycle tracking because of its high signal quality during sleep.

WHOOP

WHOOP includes a menstrual cycle tracking feature within its app:

• Cycle phase annotation on HRV and recovery graphs
• Phase-specific recovery baselines that adjust expectations based on cycle timing
• Journal feature for logging cycle-related symptoms alongside biometric data

Both platforms represent meaningful progress toward sex-specific health tracking, though neither fully adjusts all algorithms for cycle phase automatically at the time of writing.

Pregnancy and HRV

Pregnancy creates substantial cardiovascular changes that profoundly affect HRV. In the first trimester, HRV may remain stable or decrease slightly as blood volume begins expanding. By the second trimester, HRV typically decreases notably as resting heart rate rises 10-15 BPM and blood volume increases by 30-50%. In the third trimester, HRV generally reaches its lowest point, with resting heart rate 15-20 BPM above pre-pregnancy baseline.

Postpartum, HRV typically begins recovering within weeks to months after delivery, though full recovery can take 3-6 months depending on breastfeeding status, sleep quality, and overall recovery. Breastfeeding may slightly suppress HRV due to hormonal effects of prolactin and reduced estrogen.

Important note: Wearable HRV tracking during pregnancy has not been extensively validated for clinical use. Pregnant women should not use consumer wearable HRV data for medical decisions.

Menopause and HRV

During perimenopause (typically ages 45-55), HRV may become more erratic as cycles become irregular and hormones fluctuate unpredictably. Postmenopause, the sex difference in HRV narrows as estrogen declines, with postmenopausal women showing values closer to male peers. Some studies suggest estrogen-containing HRT may partially restore parasympathetic tone, though research is mixed and HRT decisions should be based on overall health considerations.

Oral Contraceptives and HRV

Combined oral contraceptives (OCs) suppress natural hormonal fluctuations, creating a more stable but generally lower HRV pattern. OC users tend to have lower HRV than non-users of the same age, likely due to the progestogenic component maintaining mild sympathetic activation. The natural follicular/luteal HRV cycle is blunted or eliminated because ovulation is suppressed. Pill-free weeks may show slight HRV increases as exogenous hormones are temporarily withdrawn.

For women using OCs who track HRV, the absence of cyclical patterns is useful: HRV changes more likely reflect genuine changes in fitness, stress, or sleep rather than normal hormonal cycling.

Practical Advice for Female Athletes Interpreting HRV

For women who use HRV tracking to guide training and recovery decisions:

• Track your cycle phase. Log your menstrual cycle in your wearable app so you can compare HRV readings to the same phase of previous cycles rather than to an absolute threshold. A "low" reading during the luteal phase may be completely normal for you.
• Establish phase-specific baselines. After 2-3 tracked cycles, you will have enough data to establish personal HRV baselines for each phase. Use these instead of a single static baseline.
• Adjust training expectations. Some athletes explore cycle-based periodization: follicular phase for high-intensity work, luteal phase for moderate endurance and recovery-focused sessions. This is supported by emerging research but individual responses vary.
• Consider the whole picture. Combine HRV with subjective wellness metrics, training load data, and cycle tracking for a complete recovery assessment.
• Do not compare directly to male norms. A woman with an RMSSD of 25ms at age 35 is at or above the female average, even though the unisex average is 32ms. Always reference sex-specific data.

The Bottom Line

Female HRV patterns are shaped by a unique combination of age-related decline, menstrual cycle hormonal fluctuations, and life events like pregnancy and menopause. Understanding these factors is essential for women who want to use HRV data meaningfully rather than misinterpreting normal physiological variation as a health concern.

The most valuable approach is to build a personal HRV profile that accounts for cycle phase, track trends over months rather than fixating on daily values, and use sex-specific reference data when comparing to norms. As wearable technology continues to evolve, expect increasingly sophisticated cycle-aware algorithms that make female HRV tracking more accurate and actionable.

For evidence-based strategies to raise your HRV regardless of sex, see our guide on how to improve heart rate variability.

Frequently Asked Questions

What is a normal HRV for a woman?

Normal HRV (RMSSD) for women varies by age: approximately 38ms for ages 20-25, 30ms for ages 30-35, 24ms for ages 40-45, 19ms for ages 50-55, and 16ms for ages 60 and above. Women typically have RMSSD values 5-15% lower than men of the same age, partly due to hormonal differences and higher resting heart rates. Individual variation is substantial, so these values are rough reference points rather than diagnostic thresholds. Your personal baseline and trend over time matter more than any population average.

How does the menstrual cycle affect HRV?

HRV fluctuates predictably across the menstrual cycle. During the follicular phase (approximately days 1-14), HRV tends to be higher due to relatively greater parasympathetic tone and rising estrogen levels. During the luteal phase (approximately days 15-28), progesterone rises and shifts autonomic balance toward sympathetic dominance, lowering HRV by approximately 5-15%. These fluctuations are normal and do not indicate a health problem. Understanding your cycle phase is essential for correctly interpreting daily HRV readings.

What is the best wearable for tracking female HRV?

The Oura Ring and WHOOP strap both offer strong HRV tracking with female-specific features. Oura Ring provides menstrual cycle phase predictions using temperature and HRV data, leveraging its accurate finger-based PPG sensor. WHOOP includes a menstrual cycle tracking feature that contextualizes HRV and recovery scores relative to cycle phase. Apple Watch also tracks HRV and offers cycle tracking in the Health app. The best choice depends on your priorities for form factor, additional features, subscription model, and budget. See our wearable comparison guide for detailed reviews.

Does pregnancy affect HRV?

Yes, substantially. During pregnancy, HRV generally decreases, particularly in the second and third trimesters, as the cardiovascular system adapts to increased blood volume (30-50% increase) and metabolic demands. Resting heart rate typically increases by 10-20 BPM during pregnancy, and sympathetic nervous system activity rises. HRV usually returns toward pre-pregnancy levels within several months postpartum, though the recovery timeline varies depending on factors like breastfeeding, sleep, and overall physical recovery. Consumer wearable HRV data should not be used for clinical pregnancy monitoring.